Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.6, 2011-06, pp. : 781-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear factor kappa B and hepatitis viruses

By Guan Yong-Song He Qing Wang Ming-Quan Li Ping

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 265-280

Informa Healthcare

Access to resources Recommend Favorite

Nuclear Factor Kappa B is a Promising Therapeutic Target in Inflammatory Lung Disease

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 661-668

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear factor-kappa B inhibitors; a patent review (2006 – 2010)

By Kwak Jae-Hwan Jung Jae-Kyung Lee Heesoon

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1897-1910

Informa Healthcare

Access to resources Recommend Favorite

Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer

Current Drug Targets, Vol. 18, Iss. 2, 2016-12 ,pp. : 232-253

Bentham Science Publishers

Access to resources Recommend Favorite

Direct Covalent Modification as a Strategy to Inhibit Nuclear Factor-Kappa B

Current Medicinal Chemistry, Vol. 16, Iss. 32, 2009-11 ,pp. : 4261-4273

Bentham Science Publishers

Access to resources Recommend Favorite